Products Categories
CAS No.: | 8015-30-3 |
---|---|
Name: | Infecundin |
Molecular Structure: | |
Formula: | C21H26O2•C20H26O2 |
Molecular Weight: | 608.93 |
Synonyms: | (17beta)-17-Ethynyl-17-hydroxyestr-5(10)-en-3-one - (17beta)-17-ethynyl-3-methoxyestra-1(10),2,4-trien-17-ol (1:1); estr-5(10)-en-3-one, 17-ethynyl-17-hydroxy-, (17beta)-, compd. with (17beta)-17-ethynyl-3-methoxyestra-1(10),2,4-trien-17-ol (1:1) |
Melting Point: | 169-170oC |
Boiling Point: | 442.3°C at 760 mmHg |
Flash Point: | 190.8°C |
Safety: | Confirmed carcinogen producing liver tumors in women by ingestion. Experimental carcinogenic, neoplastigenic, and tumorigenic data. Human reproductive effects by ingestion: menstrual cycle changes or disorders; abnormalities of the uterus, cervix, and vagina; and changes in fertility. A human teratogen that causes developmental abnormalities of the urogenital system. Experimental reproductive effects. Mutation data reported. A steroid. When heated to decomposition it emits acrid smoke and fumes. |
PSA: | 37.30000 |
LogP: | 3.63660 |
IUPAC Name: (8R,9S,13S,14S,17R)-17-Ethynyl-17-hydroxy-13-methyl-1,2,4,6,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
Synonyms of Enavid (CAS NO.8015-30-3) : (17beta)-17-Ethinyl-17-hydroxyestr-5(10)-en-3-on ; (17beta)-17-Ethynyl-17-hydroxyestr-5(10)-en-3-one ;(8R,9S,13S,14S,17R)-17-Ethynyl-17-hydroxy-13-methyl-1,2,4,6,7,8,9,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one ; 17.alpha.-Ethynyl-17.beta.-hydroxyestr-5(10)-en-3-one ; 19-Nor-17.alpha.-Pregn-5(10)-en-20-yn-3-one, 17-hydroxy-
InChI: InChI=1/C20H26O2/c1-3-20(22)11-9-18-17-6-4-13-12-14(21)5-7-15(13)16(17)8-10-19(18,20)2/h1,16-18,22H,4-12H2,2H3/t16-,17-,18+,19+,20+/m1/s1
CAS NO:8015-30-3
Molecular Formula:C20H26O2
Molecular Weight :298.4192
Molecular Structure :
Index of Refraction: 1.577
Surface Tension: 49.1 dyne/cm
Density: 1.15 g/cm3
Flash Point: 188.2 °C
Enthalpy of Vaporization: 80.66 kJ/mol
Boiling Point: 441.6 °C at 760 mmHg
Vapour Pressure: 1.19E-09 mmHg at 25°C
IARC Cancer Review: Animal Sufficient Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 6 , 1974,p. 191.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) . EPA Genetic Toxicology Program.
Confirmed carcinogen producing liver tumors in women by ingestion. Experimental carcinogenic, neoplastigenic, and tumorigenic data.Enavid (CAS NO.8015-30-3) has human reproductive effects by ingestion: menstrual cycle changes or disorders; abnormalities of the uterus, cervix, and vagina; and changes in fertility. A human teratogen that causes developmental abnormalities of the urogenital system. Experimental reproductive effects. Mutation data reported. A steroid. When Enavid (CAS NO.8015-30-3) is heated to decomposition, it emits acrid smoke and fumes.